General Information
Product name
icolung
Company
Subspeciality
Chest
Modality
CT
Disease targeted
COVID-19
Main task
Not specified
Technical Specifications
Population
All non-contrast chest CT images
Patient population age
Not specified
Input
non-contrast chest CT image
Input format
DICOM
Output
Color-coded segmentation overlays, report with quantification of lung involvement.
Output format
DICOM
Integration
Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment
Cloud-based
Trigger for analysis
Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click
Processing time
1 - 10 minutes
Regulatory Information
CE Certification
Pathway:
MDD
Class:
Class I
Verified by Health AI Register
Other certifications
Not specified
Market Presence
On market since
04-2020
AI Platforms
Bayer Pharmaceuticals, Siemens Healthineers
Resellers
Not specified
Countries present
17
Paying clinical customers
75
Research/test users
20
Pricing Information
Pricing model
Pro bono
Based on
Public need
Evidence & Research
Peer-Reviewed Papers
Peer-Reviewed
View
Automated AI-based image analysis for quantification and prediction of interstitial lung disease in systemic sclerosis patients
Source: vendor | First published: Jun 9, 2024 | Last updated: Jul 9, 2025